Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
COGT | Cogent Biosciences, Inc. | Director | $321 K | Jun 5, 2024 | ||
FMTX | Forma Therapeutics Holdings, Inc. | SVP, Chief Financial Officer | Oct 14, 2022 |
Sym | Company | Class | Transaction | % | Value $ | Price $ | Shares | Shares After | Date | Ownership |
---|